About this trial
The goal of Lesser Poland Cracovian Heart Failure Registry (LECRA-HF) is to expand the knowledge about acute heart failure (AHF) and its long-term prognosis.
The main questions are:
* assessment of long-term prognosis of AHF and its determinants * determination of the optimal AHF treatment methods * assessment of indications for invasive coronary arteries diagnostics and revascularization and their long-term effects * analysis of the particular HF subtypes (HFimpEF, HFpEF, HFsnEF, HFrEF, HFmrEF)
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
hospitalization due to acute heart failure
> 18 years of age
Disqualifiers
inability to give informed consent to participate in the registry
Trial population
The study population consists of hospitalized patients with acute heart failure who are over 18 years of age, both women and men. Patients will be initially categorized into one of three groups based on the current European Society of Cardiology (ESC) heart failure guidelines based on left ventricular ejection fraction (LVEF) values: patients with reduced (LVEF ≤40%), mildly reduced (LVEF 41-49%) and preserved (LVEF ≥50%) ejection fraction.
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
All-cause mortality
Mortality due to all causes
Secondary outcomes
Cardiovascular mortality
Mortality due to CV causes
HF rehospitalizations
Rehospitalizations related to HF decompensation
Other outcomes
LVEF increase >10% in the follow-up echocardiography
In accordance with HFimpEF definition
Sponsors and contacts
Click on the lead sponsor to view all of their trials.